Intervacc is trading about 3.8% up now at €0.09, rebounding after recent sharp, volatility-driven swings in the thinly traded small-cap biotech.
- There are no new company announcements, earnings releases, or clear catalysts reported today, suggesting the move is routine noise in a highly volatile name.
- The upward move occurs as the broader biotech sector and overall equity markets trade higher on strong earnings and supportive macro data.